Schedule 13G ownership disclosure

Immix Biopharma, Inc.

Security class unavailable · CUSIP: 45258H106

Event date: 2022-02-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-22-005810
Form type
SC 13G/A
Filer
Immix Biopharma, Inc.
CIK
CIK 1873835
Filed
Mar 02, 2022
Reporting period
Feb 25, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub